We are live on ! Find out more
PTPI

Petros Pharmaceuticals
PTPI

Delisted

PTPI was delisted on the 21st of May, 2025.

Back to rankings

12 hedge funds and large institutions have $214K invested in Petros Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

402% more capital invested

Capital invested by funds: $42.7K → $214K (+$172K)

71% more funds holding

Funds holding: 7 → 12 (+5)

0.13% more ownership

Funds ownership: 0.06% → 0.19% (+0.13%)

Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SSA
Schonfeld Strategic Advisors
New York
+$72.3K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$65.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$52.3K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$31.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$779

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$64.6K +$65.1K +836 +192%
SSA
2
Schonfeld Strategic Advisors
New York
$47.1K +$72.3K +928 New
Renaissance Technologies
3
Renaissance Technologies
New York
$34K +$52.3K +671 New
BlackRock
4
BlackRock
New York
$33.5K – – –
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$27.4K +$31.2K +400 New
TRCT
6
Tower Research Capital (TRC)
New York
$5.17K +$779 +10 +11%
EL
7
EMFO LLC
Florida
$2.03K – – –
NFSG
8
Newbridge Financial Services Group
Florida
$244 +$389 +5 New
Group One Trading
9
Group One Trading
Illinois
$160 +$234 +3 New
Morgan Stanley
10
Morgan Stanley
New York
$39 – – –
Bank of America
11
Bank of America
North Carolina
$28 – – –
Osaic Holdings
12
Osaic Holdings
Arizona
$28 – – –
Wells Fargo
13
Wells Fargo
California
$22 – – –
First Manhattan
14
First Manhattan
New York
$20 – – –

PTPI Hedge Fund Activity: Q2 2023 in Review

12 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q2 2023, worth a combined $214K — up 402% from $42.7K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PTPI positions and 0 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $72.3K.

  • 12 institutional investors held Petros Pharmaceuticals (PTPI) as of Q2 2023, up from 7 in Q1 2023.
  • Funds reported $214K of Petros Pharmaceuticals stock for Q2 2023, up 402% quarter-over-quarter.
  • 5 funds opened new Petros Pharmaceuticals positions in Q2 2023 and 0 closed out, a net change of +5 holders.
  • The largest Petros Pharmaceuticals buyer in Q2 2023 was Schonfeld Strategic Advisors, an estimated $72.3K added.

Based on aggregated 13F filings for Q2 2023.